L-arginine infusion dilates coronary vasculature in patients undergoing coronary bypass surgery

Anesthesiology

Volumn 90, Issue 6, 1999, Pages 1577-1586

  Wallace, Arthur W ^a   Ratcliffe, Mark B ^b   Galindez, Daniel ^b   Kong, James S ^b  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

CABG; Clinical trial; Nitric oxide; Vascular resistance

Indexed keywords

ARGININE; CITRULLINE; NITRIC OXIDE; R GENE 10; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD FLOW; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY BLOOD VESSEL; DOUBLE BLIND PROCEDURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAPHENOUS VEIN GRAFT; VASCULAR RESISTANCE; VASODILATATION;

AGED; ARGININE; CITRULLINE; CORONARY ARTERY BYPASS; CORONARY VESSELS; HUMANS; MIDDLE AGED; NITRIC OXIDE; PROSPECTIVE STUDIES; VASODILATION;

EID: 0033024008     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199906000-00013     Document Type: Article

References (45)

1. Chester AH, O'Neil GS, Moncada S, Tadjkarimi S, Yacoub MH: Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries (see comments). Lancet 1990; 336:897-900
2. Bossaller C, Habib GB, Yamomoto H, Williams C, Wells S, Henry PD: Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest 1987; 79:170-4
3. Golino P, Piscione F, Willerson JT, Cappelli-Bigazzi M, Focaccio A, Villari B, Indolfi C, Russolillo E, Condorelli M, Chiariello M: Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients (see comments). N Engl J Med 1991; 324:641-8
4. Pearson PJ, Schaff HV, Vanhoutte PM: Acute impairment of endothelium-dependent relaxations to aggregating platelets following reperfusion injury in canine coronary arteries. Circ Res 1990; 67: 385-93
5. Moncada S Palmer RM, Higgs EA: The biological significance of nitric oxide formation form L-arginine. Biochem Soc Trans 1989; 17: 642-4
6. Moncada S, Palmer RM, Higgs EA: Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication. Biochem Pharmacol 1989; 38:1709-15
7. Palmer RM, Rees DD, Ashton DS, Moncada S: L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation Biochem Biophys Res Commun 1988; 153: 1251-6
8. Vallance P, Collier J, Moncada S: Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man (see comments). Lancet 1989; 2:997-1000
9. Vallance P, Collier J, Moncada S: Nitric oxide synthesised from L-arginine mediates endotheliuin dependent dilatation in human veins in vivo. Cardiovasc Res 1989; 23:1053-7
10. Vallance P: The interplay between platelet and vessel-wall mediators in coronary artery occlusion. Biomed Pharmacother 1989; 43: 113-9
11. Richard V, Tanner FC, Tschudi M, Luscher TF: Different activation of L-arginine pathway by bradykinin, serotonin, and clonidine in coronary arteries. Am J Physiol 1990: 259:H1433-9
12. Clarkson P, Adams MR, Powe AJ, Donald AE, McCredie R, Robinson J, McCarthy SN, Keech A, Celermajer DS, Deanfield JE: Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. J Clin Invest 1995; 97:1989-94
13. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP: L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 1992; 90:1248-53
14. Drexler H, Zeiher AM, Meinzer R, Just H: Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991; 338:1546-50
15. Hirooka Y, Egashira K, Imaizumi T, Tagawa T, Kai H, Sugimachi M, Takeshita A: Effect of L-arginine on acetylcholine-induced endothelium-dependent vasodilation differs between the coronary and forearm vasculatures in humans. J Am Coll Cardiol 1993; 24:948-55
16. Quyyumi AA, Dakak N, Diodati JG, Gilligan DM, Panza JA, Cannon RO III: Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation. J Am Coll Cardiol 1997; 30: 1220-7
17. Quyyumi AA: Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia? A double-blind comparison of parenteral D- and L-arginine. J Am Coll Cardiol 1998; 32:904-11
18. Egashira K, Hirooka Y, Kuga T, Mohri M, Takeshita A: Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronay arteriograms (see comments). Circulation 1996; 94:130-4
19. Jain U, Laflamme CJ, Aggarwal A, Ramsay JG, Comunale ME, Ghoshal S, Ngo L, Ziola K, Hollenberg M, Mangano DT: Electrocardiographic and hemodynamic changes and their association with myocardial infarction during coronary artery bypass surgery: A multicenter study. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. ANESTHESIOLOGY 1997; 86:576-91
20. Wallace A, Layug B, Tateo I, Li J, Hollenberg M, Browner W, Miller D, Mangano D, Group MR: Prophylactic atenolol reduces post-operative myocardial ischemia. ANESTHESIOLOGY 1998; 88:7-17
21. Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S: The electrocardiogram in population studies: A classification system. Circulation 1960; 21:1160-75
22. Brace RA, Scott JB, Chen WT, Anderson DK, Haddy FJ: Direct effects of hypoosmolality on vascular resistance and myocardial contractile force (38587). Proce Soc Exp Biol Med 1975; 148:578-83
23. Stainsby WN, Fregly MJ: Effect of plasma osmolality on resistance to blood flow through skeletal muscle. Proc Soc Exp Biol Med 1968; 128:284-7
24. Rhodes P, Leone AM, Francis PL, Struthers AD, Moncada S, Rhodes PM: The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans (published erratum appears in Biochem Biophys Res Commun 1995; 211:705). Biochem Biophys Commun 1995; 190:590-6
25. Castillo L, deRojas TC, Chapman TE, Vogt J, Burke JF, Tannenbaum SR, Young VR: Splanchnic metabolism of dietary arginine in relation to nitric oxide synthesis in normal adult man. Proc Natl Acad Sci USA 1993; 90:193-7
26. Hecker M, Sessa WC, Harris HJ, Anggard EE, Vane JR: The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: Cultured endothelial cells recycle L-citrulline to L-arginine. Proc Natl Acad Sci U S A 1990; 87:8612-6
27. Hecker M, Mitchell JA, Swierkosz TA, Sess WC, Vane JR: Inhibition by L-glutamine of the release of endothelium-derived relaxing factor from cultured endothelial cells. Br J Pharmacol 1990; 101:237-9
28. Baudouin SV, Bath P, Martin JF, Du Bois R, Evans TW: L-arginine infusion has no effect on systemic haemodynamics in normal volunteers, or systemic and pulmonary haemodynamics in patients with elevated pulmonary vascular resistance. Br J Clin Pharmacol 1993; 36:45-9
29. Bode-Boger SM, Boger RH, Creutzig A, Tsikas D, Gutzki FM, Alexander K, Frolich JC: L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clin Sci (Colch) 1994; 87:303-10
30. Boger RH, Mugge A, Bode-Boger SM, Heinzel D, Hoper MM, Frolich JC: Differential systemic and pulmonary hemodynamic effects of L-arginine in patients with coronary artery disease or primary pulmonary hypertension. Int J Clin Pharmacol Ther 1996; 34:323-8
31. Amrani M, Gray CC, Smolenski RT, Goodwin AT, Iondon A, Yacoub MH: The effect of L-arginine on myocardial recovery after cardioplegic arrest and ischemia under moderate and deep hypothermia. Circulation 1997; 96:11-274-9
32. Lee R, Nitta T, Schmid RA, Schuessler RB, Harris KM, Say WA Jr. Retrograde infusion of lidocaine or L-arginine before reperfusion reduces myocardial infarct size. Ann Thorac Surg 1998; 65:1353-9
33. Mizuno T, Watanabe M, Sakamoto T, Sunamori M: L-arginine, a nitric oxide precursor, attenuates ischemia-reperfusion injury by inhibiting inositol-1,4,5-triphosphate. J Thorac Cardiovasc Surg 1998; 115:931-6
34. Szabo G, Bahrle S, Batkai S, Stumpf N, Dengler TJ, Zimmerman R, Vahl CF, Hagl S: L-arginine: Effect on reperfusion injury after heart transplantation. World J Surg 1998; 22:791-7; discussion 797-8
35. Szabo G, Batkai S, Bahrle S, Dengler TJ, Vahl CF, Zimmermann R, Hagl S: Effects of nitric oxide synthesis on reperfusion injury and catecholamine responsiveness in a heterotopic rat heart-transplantation model. J Cardiovasc Pharmacol 1998; 31:221-30
36. Drexler H, Fischell TA, Pinto FJ, Chenzbraun A, Botas J, Cooke JP, Alderman FL: Effect of L-arginine on coronary endothelial function in cardiac transplant recipients: Relation to vessel wall morphology. Circulation 1993; 89:1615-23
37. Ceremuzynski L, Chamiec T, Herbaczynska-Cedro K: Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris. Am J Cardiol 1997; 80:331-3
38. Lerman A, Burnett JC Jr, Higano ST, McKinley LJ, Holmes DR Jr: Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans (in process citation). Circulation 1998; 97:2123-8
39. Otomo J, Nozakl N, Tomoike H: Roles of nitric oxide and adenosine in the regulation of coronary conductance in the basal state and during reactive hyperemia. Jpn Circ J 1997; 61:441-9
40. Gryglewski RJ , Chlopicki S, Niezabitowski P: Myocardial reactive hyperaemia in perfused guinea pig heart. Pol J Pharmacol 1997; 47:479-83
41. Gryglewski RJ, Chlopicki S, Niezabitowski P, Jakubowski A, Lomnicka M: Ischaemic cardiac hyperaemia: Role of nitric oxide and other mediators. Physiol Res 1996; 45:255-60
42. Macho P, Domenech R, Penna M: Relative participation of adenosine and endothelium derived mediators in coronary reactive hyperemia in the dog. Biol Res 1997; 28:165-71
43. Sagach VF, Tkachenko MN: Role of nitric oxide in myocardial reactive hyperemia in a dog. Pol J Pharmacol 1994; 46: 609-14
44. Huckstorf C, Zanzinger J, Fink B, Bassenge E: Reduced nitric oxide formation causes coronary vasoconstriction and impaired dilator responses to endogenous agonists and hypoxia in dogs. Naunyn Schmiedebergs Arch Pharmacol 1994; 349:367-73
45. Bode-Boger SM, Boger RH, Alike H, Heinzel D, Tsikas D, Creutzig A, Alexander K, Frolich JC: L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia: A randomized, controlled study. Circulation 1996; 93:85-90